StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 7, 2026, 07:12 AM

Embecta Q3 Revenue $271.7M, Adjusted EPS $0.56; Raises FY26 Guidance

AI Summary

Embecta Corp. reported third-quarter fiscal 2026 results with revenues of $271.7 million, an 8.1% decrease year-over-year, and adjusted diluted EPS of $0.56, down from $1.12. Despite the year-over-year declines, the company noted significant sequential improvement in revenue and operating income. Embecta reaffirmed its fiscal year revenue guidance and raised its full-year adjusted operating margin and adjusted earnings per share guidance, following the acquisition of Owen Mumford and strategic debt repayment.

Key Highlights

  • Q3 2026 reported revenues decreased 8.1% to $271.7 million.
  • Q3 2026 adjusted diluted EPS was $0.56, down from $1.12 YoY.
  • Raised fiscal year 2026 adjusted operating margin guidance to 23.50% - 24.00%.
  • Raised fiscal year 2026 adjusted EPS guidance to $1.80 - $1.90.
  • Repaid approximately $53 million of debt during the quarter.
  • Repurchased approximately $9 million of shares.
  • Completed the acquisition of Owen Mumford Holdings Limited.
  • Declared a quarterly cash dividend of $0.01 per share.